medigraphic.com
ISSN 0016-3813 (Print)

2002, Number S1

<< Back Next >>

Gac Med Mex 2002; 138 (S1)

Extranodal Lymphomas

Figueroa-Sandoval JF, Avilés-Miranda A, Cervera-Cevallos EE, Labardini-Mendez J

Language: Spanish
References: 40
Page: 118-125
PDF size: 58.63 Kb.


Text Extraction

No abstract


REFERENCES

  1. Parkin DM, Pisan P. Estimates Of the worldwide incidence of eighteen major cancer in 1985: Int. J Cancer 1993; 54: 594-606.

  2. Dirección General de Epidemiología. Registro Historpatológico de Neoplasias Malignas en México. Morbilidad y Mortalidad. Bienio 1993-1994. Tendencias 1985-1994. México: Secretaría de Salud, México 1996.

  3. Mohar A, Sobrevilla P. Velásquez W. Linformas. Rev Invest Clin 1997;49: 56-63.

  4. Itami J, Itami M, Mikata A, et al. Non-Hodgkin’s lymphoma confined to the nasal cavity. Its relationship to the polymorphic reticulosis and results of radiation therapy. Int J Radiat Oncol Biol Phys 1991;20:797-802.

  5. Cheong MC, Chau JKL, Law WH, et al. Primary non-Hodgkin’s of the nose and nasopharynx . J Clin Oncol 1998;16:70-77.

  6. Kwong YL, Chan ACL, Liang R, et al. CD56+ lymphomas. Br J Haematol 1997;88:821-829.

  7. Avilés A, Ródriguez L, Guzmán R, et al. Angiocentric T-cell lymphoma of the nose, paranasal sinuses and hard palate. Hematol Oncol 1992;10:141-145.

  8. Avilés A, Díaz NR, Neri N, et al. Angiocentric nasal T/NK cell lymphoma. Clin Lab Haematol 2000;22:215-220.

  9. Shikama N, Ikeda H, Nakamura S, et al. Localized aggressive non-Hodgkin’s lymphoma of the nasal cavity. A survey by the Japan Lymphoma Radiation Therapy Group. Int J Radiat Oncol Biol Phys 2001;51:1228-1233.

  10. Ribaut R, Haji E, Girinsky JA, et al. Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma.Leukemia 2000: 15: 1123-1126.

  11. Kiego H, Ho CJ, Ickyo W, et al. Angiocentrioc lymphoma of the head and neck. Patterns of systemic relapse after radiation therapy. J Clin Oncol 2000;18:54-63.

  12. Avilés A, Delgado S, Fernández A, et al.: Combined therapy in angioimmunoproliferative lesions . Eur J Cancer 1994; 30B:302-304.

  13. Sobrevilla CP, Meneses A, Alfaro R, et al. Radiotherapy compared to chemotherapy as initial treatment of angiocentric centrofacial lymphoma. Acta Oncol 1993;32:69-72.

  14. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin´s lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997;8:727-37.

  15. Zucca E, Cavalli F. Extranodal lymphomas. Ann Oncol 2000; 11(suppl 3): 219-22.

  16. Ibrahim E, Ezzat A, Roja M, Rahal M. Primary gastric non-Hodgkin´s lymphoma: clinical features, management, and prognosis of 185 patients with diffuse large B-cell lymphoma Ann Oncol 1999;10: 1441-49.

  17. Isaacson PG. Gastric MALT lymphoma: for concept to cure. Ann Oncol 1999; 10: 637-45.

  18. Wotherspoon AC, Ortiz-HidalgoC, Falzan MR, et al. Helicobacter pylori-associated gastritis and primary B cell gastric lymphoma. Lancet 1991;338:1175-76.

  19. Coiffier B, Salles G. Does surgery belong to medical history for gastric lymphoma? Ann Oncol 1997;8:419-21.

  20. Harris NL, Jaffe ES, Stein, et al. A revised European -American Classification of Lymphoid Neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361-92.

  21. Alpen B, Thiede C, Wundish T, et al. Molecular diagnostics in low-grade gastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type after Helicobacter pylori erradication therapy. Clini Lymph 2001; Sept: 103-8.

  22. Starostik P, Patzner J, Greiner A, Schwarz S, Kalla J, Ott G, et al. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood 2002; 99:3-9.

  23. Fonseca R, Habermann TM, Colgan JP, et al. Testicular lymphoma is associated with high incidence of extranodal recurrence. Cancer 2000;88:154-61.

  24. Gospodarowicz MK, Zucca E. Primary testis lymphoma: presentation, treatment, patterns of failure, and outcomes. Proceedings Asco, 2001:281-5.

  25. Lagrange JL, Ramaioli A, Theodore CH, et al. Non-Hodgkins lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centers. Ann Oncol 2001;12:1313-9.

  26. Leite KR, Garicochea B, Srougi M, et al. Monoclonality of asynchronous bilateral lymphoma of the testis. Eur Urol 2000;38:774-7.

  27. Figueroa Sandoval J, F. Briseño Torres R, Peña P, Aguilar López L. Linfoma Primario del Sistema Nervioso Central(Experiencia del H.E.C.M.O)Revista de Hematología 2001;2:6-8.

  28. De Angelis LM. Current management of primary central nervous system lymphoma. Oncology1995;9:63-71.

  29. Helle TD et al. Primary central nervous system lymphoma clinopathological study of experience at Standford Journal of Neurosurgery 1981;60:94-103.

  30. Pollack JF, Lunsford LD, Flickinger JC. Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 1989;63:939.

  31. Laperriere NJ, Cerezo L, Melosevic MF et al. Primary lymphoma of brain: results of management of a modern cohort with radiation therapy. Radiother-Oncol 1997;43:247-52.

  32. Blay JY, Ongolo Zogo P, Sebban C. Primary cerebral lymphoma: unsolved issues regarding first line treatment, follow-up, late neurological toxicity and treatment of relapses. The FNCLCC. Ann Oncol 2000;11:39-44.

  33. Reni M, Ferreri AJ, Guha Thakurta N, Yves Blay J et al. Clinical relevance of consolidation radiotherapy and other main Therapeutic issues in primary central nervous system lymphomas treated with upfront high dose methotrexate. Int J. Radiation Oncology Biol Phys 2001;51:419-425.

  34. Skarin AT ,Zuckerman KS, Pitman SN. High dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin´s lymphoma including CNS involmente Blood 1977;50:1039-1047.

  35. Abrey LE, Yahalom J, De Angelis LM. Treatment for primary CNS lymphoma: The next step. J. Clin Oncol 2000;18:3144-50.

  36. Cher L,Glass J,Harsh GR et al.Therapy of primary CNS lymphoma with methotrexate based chemotherapy and deferred radiotherapy:preliminary results.Neurology 1996;46:1757.

  37. De Angelis LM, Yahalom J, Thaler HT, et al. Combined modality therapy for primary CNS lymphoma. J. Clin. Oncol 1992;10:635-43.

  38. Sandor V, Stark-Vancs, Pearson D. Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J. Clin Oncol 1998;16:3000-6.

  39. Nelson DF, Mart KL, Bonner H et al. Non-Hodgkin´s lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the RTOG8315. International Journal of Radiation Oncology Biology and Physic 1992;23:9-17.

  40. Bessell EM, Graus F, López Guillermo, Villa S et al. CHOD/BVAM. Regimen plus radiotherapy in patient with primary CNS Non Hodgkin´s lymphoma. Int. J. Radiation Oncology Biol Phys 2001;50:457-464.




2020     |     www.medigraphic.com